Phase III trial of becaplermin for diabetic foot ulcer treatment (European trial).
Phase of Trial: Phase III
Latest Information Update: 18 Mar 2013
At a glance
- Drugs Becaplermin (Primary)
- Indications Diabetic foot ulcer
- Focus Registrational; Therapeutic Use
- 18 Mar 2013 Planned initiation date changed from 1 Dec 2013 to 1 Jul 2014, as reported in an Adocia media release.
- 27 Apr 2012 New trial record